Compare MWH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MWH | GRFS |
|---|---|---|
| Founded | 2008 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.9B |
| IPO Year | 2026 | 2008 |
| Metric | MWH | GRFS |
|---|---|---|
| Price | $25.12 | $7.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $35.42 | $10.15 |
| AVG Volume (30 Days) | ★ 1.2M | 385.3K |
| Earning Date | 03-19-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.86 | $4.49 |
| Revenue Next Year | $14.78 | $6.42 |
| P/E Ratio | $227.73 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.83 | $6.96 |
| 52 Week High | $48.40 | $10.23 |
| Indicator | MWH | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 40.94 |
| Support Level | $23.88 | $7.33 |
| Resistance Level | $30.74 | $8.41 |
| Average True Range (ATR) | 1.18 | 0.11 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 26.00 | 25.00 |
SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.